The conflict between treatment optimization and registration of radiopharmaceuticals with fixed activity posology in oncological nuclear medicine therapy
(2017) In European Journal of Nuclear Medicine and Molecular Imaging 44(11). p.1783-1786
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/eefc8fc6-4b0a-461b-8967-7db9e5938e8f
- author
- organization
- publishing date
- 2017-05-24
- type
- Contribution to journal
- publication status
- published
- subject
- in
- European Journal of Nuclear Medicine and Molecular Imaging
- volume
- 44
- issue
- 11
- pages
- 4 pages
- publisher
- Springer
- external identifiers
-
- pmid:28536834
- wos:000408337300001
- scopus:85019937751
- ISSN
- 1619-7070
- DOI
- 10.1007/s00259-017-3707-3
- language
- English
- LU publication?
- yes
- id
- eefc8fc6-4b0a-461b-8967-7db9e5938e8f
- date added to LUP
- 2017-06-30 14:10:48
- date last changed
- 2025-04-16 06:04:55
@article{eefc8fc6-4b0a-461b-8967-7db9e5938e8f, author = {{Chiesa, C. and Sjogreen Gleisner, K. and Flux, G. and Gear, J. and Walrand, S. and Bacher, K. and Eberlein, U. and Visser, E. P. and Chouin, Nicolas and Ljungberg, M. and Bardiès, M. and Lassmann, M. and Strigari, L. and Konijnenberg, Mark W}}, issn = {{1619-7070}}, language = {{eng}}, month = {{05}}, number = {{11}}, pages = {{1783--1786}}, publisher = {{Springer}}, series = {{European Journal of Nuclear Medicine and Molecular Imaging}}, title = {{The conflict between treatment optimization and registration of radiopharmaceuticals with fixed activity posology in oncological nuclear medicine therapy}}, url = {{http://dx.doi.org/10.1007/s00259-017-3707-3}}, doi = {{10.1007/s00259-017-3707-3}}, volume = {{44}}, year = {{2017}}, }